Live data from Hacker News

Why I’m Digging Deep Into Alzheimer’s

gatesnotes.com

141–150 of 192 posts

Re: Why I’m Digging Deep Into Alzheimer’s

#141

I love that Gates is driving money into this needed area. We need new ways of attacking cures and the tech arena should be the driver not science. IMO, traditional science has gotten in the way and their agenda isn't where it needs to be: to find a a cure and save lives (take cancer research for instance).

I don't understand why you think tech companies will be any better at this than biomedical companies. All businesses have the same incentives to make things chronic issues (subscription revenue!) rather than curing them.

Re: Why I’m Digging Deep Into Alzheimer’s

#142

Funny, I remember contacting the Gates foundation many years ago now about chronic illnesses and the then-new discovery of ipRGCs/pRGCs (which we will find have a critical role in Alzheimer's) and hitting a total brick wall. Paraphrasing them, "this wouldn't help the third world" - we know better now.

Nothing will help the third world more than effective vaccines for children so that living past 5 is not an anomaly. I would expect the Gates foundation to focus on that. Quality of life for old people is a nice thing, but not on the same level.

As a rule when children normally live to adulthood population growth halts soon after.

Re: Why I’m Digging Deep Into Alzheimer’s

#143

Earlier quoted context omitted.

Thanks. I’m still not understanding how so many people could acquire Lyme disease and not have any of the other symptoms.

Because Lyme is often asymptomatic, other than the initial rash!

Lyme can be asymptomatic for _years_ and in many cases it doesn't even cause the initial rash!

Re: Why I’m Digging Deep Into Alzheimer’s

#144

The documentary "Under our Skin" details Alan MacDonald's breakthrough research on how Lyme disease causes Alzheimers. The 4 minute trailer is worth a watch[1], but basically Lyme disease is found in 7 or 10 brains of Alzheimers patients (small sample set). The Lyme disease spirochete literally drills countless pathways in the brain and that causes slow dementia. That spirochete also creates a biofilm which makes it…

As for how a citizen scientist proceeds, go to pubmed.com and read the abstracts of at least 400,000 medical articles. I did.

quality > quantity

I doubt there are 400,000 papers worth reading in all of medicine. A major skill in research is understanding what to read, and how carefully.

Prepping to write a review usually involves about 150 articles, for me. About 50 of them just need a cursory look, and the abstract often suffices. Another 80 or so need some more attention; you might be looking for patterns in the methods used, cross-referencing results, figuring out what labs are doing what, tracking authors over time, etc. This is how you understand the state of a field.

The last 20 or so are the bulk of your time. A few are genuinely excellent and will be a highlight of the review. Some are simply solid work that requires a good amount of attention. A fair number are terrible and highly misleading. These are the papers that look okay, but have some flaws that need to be addressed by the field at large. It takes some tact to write about these, but it's usually not too bad.

Finding good authors, especially ones that write good reviews, can get you up to speed in a field in an afternoon. An evening chasing down citations and digging a bit on your own, and you're probably about where Bill was with this. Since Alzheimer's is a pretty big subject requiring familiarity with a variety of topics, I'd give it two weeks.

Re: Why I’m Digging Deep Into Alzheimer’s

#145

I love that Gates is driving money into this needed area. We need new ways of attacking cures and the tech arena should be the driver not science. IMO, traditional science has gotten in the way and their agenda isn't where it needs to be: to find a a cure and save lives (take cancer research for instance).

I don't understand why you think tech companies will be any better at this than biomedical companies. All businesses have the same incentives to make things chronic issues (subscription revenue!) rather than curing them.

Because I recently read a really interesting story that talked about how science tends to get in the way of real progress. I hope you don't mind me sharing it with you but it struck a real note with me. http://www.thenewatlantis.com/publications/saving-science

Re: Why I’m Digging Deep Into Alzheimer’s

#146
post #20

It's great to see more investment into this disease. When my grandma fought Alzheimer's over the span of a decade it was very striking to see that the effect of a lack of hydration and the disease itself kind of overlapped. When she had a particularly bad day we used to give her a saline IV and you could immediately notice how she cleared up and regained her brain powers after each IV. I'm not up to date on current r…

The other side of that is that there are many non-Alzheimer's causes of dementia in elderly patients. If a patient has dementia symptoms (along with a bunch of other problems) it can be really difficult for doctors to diagnose the root cause. For example my grandma's mental capacity was slowly deteriorating and they eventually determined it was because her bone marrow wasn't producing enough red blood cells, thus reducing the oxygen supply to her brain.

There have been attempts to build a wearable hydration sensor but no one has made the technology work reliably yet. It's a big potential market if someone can find a solution.

https://www.dcrainmaker.com/2016/09/bsx-announces-kickstarte...

Re: Why I’m Digging Deep Into Alzheimer’s

#147
> We need to use data better. Every time a pharmaceutical company or a research lab does a study, they gather lots of information. We should compile this data in a common form [...]

We could use all sorts of data, not just from research or pharmaceutical companies. Is there an overview of what data is available or planned for, from clinical to commercial? And what data-integration platforms are planned for? I suspect many countries are trying to invent this on their own, while a world-wide approach could yield better results.

Re: Why I’m Digging Deep Into Alzheimer’s

#150

> We need to use data better. Every time a pharmaceutical company or a research lab does a study, they gather lots of information. We should compile this data in a common form [...] We could use all sorts of data, not just from research or pharmaceutical companies. Is there an overview of what data is available or planned for, from clinical to commercial? And what data-integration platforms are planned for? I suspect…

How do you motivate a pharmaceutical company to share R&D they spent millions acquiring?
Post reply on HN